Algo version: 0.98b
ERYP is listed at the NASDAQ Exchange
ERYP [ERYP]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is ERYP stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for ERYTECH Pharma SA 10 years ago, but if you had invested on Tuesday 5th of July 2016 when the price was $24.40, you would have made a loss of $-23.62 per share or -96.80%

No, the average daily trading liquidity for ERYTECH Pharma SA is $93 698 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

ERYTECH Pharma SA has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for ERYTECH Pharma SA to be high [0.75 out of 1]